Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review

Interstitial lung disease (ILD) is a major pulmonary complication of autoimmune rheumatic diseases (ARD) and a leading contributor to long-term morbidity and mortality. Although ARDs share underlying immune dysregulation, the onset, radiologic phenotype, and clinical course of ILD vary substantially across individual diseases. Consequently, early detection and structured risk stratification at baseline and during follow-up have become essential elements of care for patients at risk of ARD-related ILD. This review examines the principles and emerging strategies for early identification of ARD-related ILD, emphasizing the role of systematic clinical assessment, high-resolution computed tomography, and longitudinal pulmonary function evaluation in detecting early lung involvement. We discuss how radiologic patterns, functional measures, and serological profiles contribute to prognostic classification in different autoimmune contexts, with particular focus on the early identification of patients at risk of rapid ILD progression. Disease-specific ILD patterns are reviewed across major autoimmune conditions—including systemic sclerosis, idiopathic inflammatory myopathies, primary Sjögren’s syndrome, mixed connective tissue disease, systemic lupus erythematosus, rheumatoid arthritis, and anti-neutrophil cytoplasmic antibody-associated vasculitis—each characterized by distinct risk factors, distinct imaging findings, and divergent prognostic trajectories. Finally, we highlight emerging approaches to risk stratification, including integrated models that combine clinical, radiologic, and serological domains to mitigate the risk of disease progression and guide monitoring strategies. Overall, current evidence supports a precision-medicine framework for ARD-related ILD, in which early recognition and individualized assessment of progression risk are crucial to improving outcomes and informing therapeutic decision-making.

Authors

Institutions

Publication Details

Journal
Respiratory Research
Published
2026-02-06
DOI
https://doi.org/10.1186/s12931-026-03538-0
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review

Giovanni Franco, Umberto Zanini, Paolo Delvino, Carlo Trentanni et al.
Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review

Giovanni Franco, Umberto Zanini, Paolo Delvino, Carlo Trentanni, Valentina Bondi, Fabrizio Luppi, Carlo Alberto Scirè, Giulia Puccetti
article en

Abstract

Interstitial lung disease (ILD) is a major pulmonary complication of autoimmune rheumatic diseases (ARD) and a leading contributor to long-term morbidity and mortality. Although ARDs share underlying immune dysregulation, the onset, radiologic phenotype, and clinical course of ILD vary substantially across individual diseases. Consequently, early detection and structured risk stratification at baseline and during follow-up have become essential elements of care for patients at risk of ARD-related ILD. This review examines the principles and emerging strategies for early identification of ARD-related ILD, emphasizing the role of systematic clinical assessment, high-resolution computed tomography, and longitudinal pulmonary function evaluation in detecting early lung involvement. We discuss how radiologic patterns, functional measures, and serological profiles contribute to prognostic classification in different autoimmune contexts, with particular focus on the early identification of patients at risk of rapid ILD progression. Disease-specific ILD patterns are reviewed across major autoimmune conditions—including systemic sclerosis, idiopathic inflammatory myopathies, primary Sjögren’s syndrome, mixed connective tissue disease, systemic lupus erythematosus, rheumatoid arthritis, and anti-neutrophil cytoplasmic antibody-associated vasculitis—each characterized by distinct risk factors, distinct imaging findings, and divergent prognostic trajectories. Finally, we highlight emerging approaches to risk stratification, including integrated models that combine clinical, radiologic, and serological domains to mitigate the risk of disease progression and guide monitoring strategies. Overall, current evidence supports a precision-medicine framework for ARD-related ILD, in which early recognition and individualized assessment of progression risk are crucial to improving outcomes and informing therapeutic decision-making.

Respiratory ResearchVol. 27(1)
Azienda Ospedaliera San Gerardo (IT), Società Italiana di Reumatologia (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Milano-Bicocca (IT)
Good health and well-being
Openalex Percentile: Top 66%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.